Skip to main content
Log in

Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Although peritoneal lavage cytology is widely performed during surgery for gastric cancer and the results have been reported to be one of the accurate prognostic factors, the cancer stage is determined independent of the results of lavage cytology according to the First English Edition of Japanese Classification of Gastric Carcinoma. In this study we demonstrated the validity of lavage cytology for accurately staging gastric cancer. Between 1988 and 1996, peritoneal lavage cytology was performed in 347 patients with resectable gastric cancer. Among them, cytology was positive in 29 cases (8.4%). The survival rate of the cytology-positive patients in each stage was worse than that of all patients in the same stage. The prognosis of patients with positive cytology findings and serosa-exposed gastric cancer was significantly worse than that of negative cytology findings and serosa-exposed gastric cancer, and similar to that of negative cytology findings and serosa-infiltrating gastric cancer. Our data indicated that positive cytology findings thus indicated a poor prognosis, and the prognostic difference between positive and negative cytology findings was approximately a one-stage difference in the Japanese stage grouping. Based on our findings, the results of peritoneal lavage cytology should thus be included in the factors for staging gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ, German Gastric Carcinoma Study Group (1993) Prognostic relevance of systemic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018

    Article  CAS  PubMed  Google Scholar 

  2. Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ohigashi H, Nakamori S, Nakano H, Yasuda T (1996) Adjuvant chemotherapy for advanced gastric cancer (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 97:312–316

    CAS  PubMed  Google Scholar 

  3. Ichikura T, Fujino K, Tomimatsu S, Uefuji K, Tamakuma S (1993) Proposal of a risk score for recurrence in patients with curatively resected gastric cancer. Surg Today 23:759–764

    Article  CAS  PubMed  Google Scholar 

  4. Ohno S, Maehara Y, Ohiwa H, Oshiro T, Kakeji Y, Baba H, Furusawa M, Sugimachi K (1994) Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach. Semin Surg Oncol 10:117–120

    Article  CAS  PubMed  Google Scholar 

  5. Nakajima T, Harashima S, Hirata M, Kajitani T (1978) Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22:225–229

    CAS  PubMed  Google Scholar 

  6. Iitsuka Y, Shiota S, Matsui T, Murata Y, Kimura A, Koga S (1990) Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 34:437–442

    CAS  PubMed  Google Scholar 

  7. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M (1990) Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77:436–439

    Article  CAS  PubMed  Google Scholar 

  8. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara M (1994) Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 14:2131–2134

    CAS  PubMed  Google Scholar 

  9. Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, Nagaoka S (1995) Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59:226–229

    Article  CAS  PubMed  Google Scholar 

  10. Bonenkamp JJ, Songun I, Hermans J, Verde CJH, the cooperative investigators of the Dutch Gastric Cancer Trial (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83:672–674

    Article  CAS  PubMed  Google Scholar 

  11. Japanese Research Society for Gastric Cancer (1993) Japanese Classification of Gastric Carcinoma, First English edition. Kanehara, Tokyo

    Google Scholar 

  12. Moore GE, Sako K, Kondo T, Badillo J, Burke E (1961) Assessment of the exfoliation of tumor cells into the body cavities. Surg Gynecol Obstet 112:469–474

    CAS  PubMed  Google Scholar 

  13. Japanese Research Society for Gastric Cancer: Miwa Registry-Institute for Stomach Cancer (1996) The Report of Treatment Results of Stomach Carcinoma in Japan. Miwa Registry-Institute for Stomach Cancer, Tokyo, p 62

    Google Scholar 

  14. Nishiyama M, Takashima I, Tanaka T, Yoshida K, Toge T, Nagata N, Iwamori S, Tamura Y (1995) Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 19:133–137

    Article  CAS  PubMed  Google Scholar 

  15. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S (1979) Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 44:1476–1480

    Article  CAS  PubMed  Google Scholar 

  16. Jones AL, Trott P, Cunningham D, Rosin RD, Coleman D, Sauven P, Glazer G, Hermon-Taylor J, Coombes RC, Stein R, Parker M, Kirkham J (1994) A pilot study of intraperitoneal cisplatin in the management of gastric cancer. Ann Oncol 5:123–126

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, T., Ochiai, T., Hayashi, H. et al. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 29, 111–115 (1999). https://doi.org/10.1007/BF02482234

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482234

Key Words

Navigation